While your liver is a critical organ, it is also vulnerable to the toxins it processes. Too many toxins can overwhelm your ...

Metabolic-associated steatohepatitis (MASH) happens when excess fat in the liver causes inflammation and scarring, or fibrosis. The condition is serious, and when left untreated it can lead to ...

In a second poster, spatial computational histology relying on baseline fibrosis features was used to predict response to denifanstat ...

Fatty liver disease has become one of the most common liver problems across the world. Two forms stand out: non-alcoholic ...

In phase 2 trials involving patients with stage 2 or 3 fibrosis caused by metabolic dysfunction–associated steatohepatitis (MASH), efruxifermin, a bivalent fibroblast growth factor 21 (FGF21) analogue ...

Lactulose and tai chi can prevent falls in patients with cirrhosis, according to results from the LiveSMART Trial. Michigan ...

Fatty liver disease is a health condition in which fat builds up in the liver. This fat buildup can cause inflammation and, in severe cases, liver damage. There are two main types of fatty liver ...

There are two FDA-approved medications for the metabolic disorder known as MASH. Roche is paying $2.4 billion to acquire 89bio and its late-stage MASH drug, giving the Swiss pharmaceutical giant the ...

Men with cirrhosis had higher risks for adverse liver events than women, including more than twice the risk for hepatocellular carcinoma. This sex-based risk disparity was more pronounced in nonviral ...